The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
Abstract
Riboflavin, which improves energy metabolism similarly to coenzyme Q10 (CoQ10), is effective in migraine prophylaxis. We compared CoQ10 (3 x 100 mg/day) and placebo in 42 migraine patients in a double-blind, randomized, placebo-controlled trial. CoQ10 was superior to placebo for attack-frequency, headache-days and days-with-nausea in the third treatment month and well tolerated; 50%-responder-rate for attack frequency was 14.4% for placebo and 47.6% for CoQ10 (number-needed-to-treat: 3). CoQ10 is efficacious and well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698
Price, D. D., Milling, L. S., Kirsch, I., Duff, A., Montgomery, G. H., & Nicholls, S. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00081-0 · Cited by 561
Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial
Schoenen, J., Jacquy, J., & Lenaerts, M. (1998) · Neurology · doi:10.1212/wnl.50.2.466 · Cited by 548
Self-citationWelch, K. M. A., Levine, S. R., D'Andrea, G., Schultz, L. R., & Helpern, J. A. (1989) · Neurology · doi:10.1212/wnl.39.4.538 · Cited by 205
Open Label Trial of Coenzyme Q10 as A Migraine Preventive
Rozen, T., Oshinsky, M., Gebeline, C., Bradley, K., Young, W., Shechter, A., & Silberstein, S. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00335.x · Cited by 172
MELAS syndrome with mitochondrial tRNA Leu[UUR] mutation
Penn, A. M. W., Lee, J. W. K., Thuillier, P., Wagner, M., Maclure, K. M., Menard, M. R., Hall, L. D., & Kennaway, N. G. (1992) · Neurology · doi:10.1212/wnl.42.11.2147 · Cited by 124
Shults, C. W., Beal, M. F., Fontaine, D., Nakano, K., & Haas, R. (1998) · Neurology · doi:10.1212/wnl.50.3.793 · Cited by 116
Nishikawa, Y., Takahashi, M. M., Yorifuji, S., Nakamura, Y., Ueno, S., Tarui, S., Kozuka, T., & Nishimura, T. (1989) · Neurology · doi:10.1212/wnl.39.3.399 · Cited by 100
Effectiveness of high-dose riboflavin in migraine prophylaxis
Yee, A. J., & Schoenen, J. E. (1999) · Neurology · doi:10.1212/wnl.52.2.431-a · Cited by 85
Self-citationWatanabe, H., Kuwabara, T., Ohkubo, M., et al. (1996) · Neurology · doi:10.1212/wnl.47.4.1093 · Cited by 81
Cited by
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism
Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677
Antioxidant Therapy: Current Status and Future Prospects
Firuzi, O., Miri, R., Tavakkoli, M., & Saso, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711803414368 · Cited by 468
Riboflavin and health: A review of recent human research
Thakur, K., Tomar, S. K., Singh, A. K., Mandal, S., & Arora, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1145104 · Cited by 349
Holland, S., Silberstein, S. D., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d0c · Cited by 347
Metadata
- Authors
- Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., Magis, D., Seidel, L., Agosti, R. M., & Schoenen, J.
- Venue
- Neurology
- Published
- 2005-02-22
- Volume
- 64
- Issue
- 4
- Pages
- 713-715
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2128676798
- Cited by
- 371
- References
- 10
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. https://app.cochat.ai/papers/10.1212/01.wnl.0000151975.03598.ed
- The paper
- Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., Magis, D., Seidel, L., Agosti, R. M., & Schoenen, J. (2005). Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurology. https://doi.org/10.1212/01.wnl.0000151975.03598.ed
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.